(*) USA Launch Date: 2020. 03.02.
>mation>Treat.>Antibiotic+Dexametha
Antibiotic: Tobramycin
Blepharitis & MGD
Company
MGD: meibomian gland dysfunction
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2021. 11.16
RTM
RTM Web-Site